In this study, we showed that mRNA vaccinated blood donors have a median of 17 times higher RBD antibody levels when compared with those who became seropositive due to prior COVID-19.
The vaccinated blood samples, due to their much-elevated RBD antibody levels, were far more effective.
Our results indicated that the antisera from natural immunity would be less effective against new variants.